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The effect of increasing extracellular potassium concentration (Ko) upon electrical ventricular 
defibrillation threshold was investigated in pentobarbital anesthetized dogs treated with 
intravenous potassium chloride. Defibrillation threshold fell during potassium intoxication. The 
percent decrease in defibrillation threshold was linearly related to the logarithm of Ko and to the 
potassium equilibrium potential, EK, calculated from measured extracellular and intracellular 
potassium concentrations of ventricular muscle. In dogs supported by left ventricular bypass in 
order to maintain the circulation during potassium intoxication, the values of Ko and EK required 
for spontaneous, K+ induced defibrillation (electrical defibrillation threshold  = zero) were 16.6 
mEq/L and -46 mV compared to the normal values of 3.9 mEq/L and -84 mV. Changes in 
defibrillation threshold related to changes in EK may be significant events in digitalis intoxication 
and in myocardial anoxia during prolonged fibrillation. 
 
Defibrillation of the heart is often discussed as a large scale analog of cardiac pacing. 
Termination of atrial or ventricular fibrillation by a strong electric shock, applied with paddle 
electrodes across the chest or directly to the heart, is assumed to be the result of stimulation of a 
diffuse mass of potentially excitable cells (1, 2). The mechanism of defibrillation is usually 
stated to be the consequent production of a simultaneously refractory state in the entirety of a 
critical mass of the fibrillating myocardium (3, 4).  
 






The present report describes a pharmacologic test of this hypothesis. If indeed the process of 
fibrillation is analogous to electrical excitation of a single resting myocardial cell, then the shock 
intensity required for defibrillation should decrease if cardiac cells are partially depolarized by 
pre-treatment with a drug such as potassium chloride. In particular, the shock strength required 
for defibrillation should be proportional to the difference between the resting membrane potential 
of non-excited cells in the fibrillating myocardium and the firing or threshold potential of these 
 
cells. Defibrillation should be accomplished with zero electric shock at a transmembrane 
potential approximately equal to the firing threshold -50-60 mV in typical preparations (5, 6).  
Indeed, before the existence of electrical defibrillators, chemical defibrillation, developed by 
Hooker (7), was practiced at surgery by flushing the coronary vascular bed with potassium 
solution (8). 
 
The ratio of intracellular potassium concentration, Ki , to extracellular potassium 
concentration, Ko, is a major determinant of the resting transmembrane potential. A 
first order approximation of the transmembrane potential is given by the Nernst 




Under physiologic conditions, measured resting transmembrane potentials are 
slightly less negative than this value due to inward leakage of sodium ions (5, 9). 
Note that because Ki is normally much greater than Ko  (90 – 150 mEq/L vs. 2 - 5 
mEq/L) small absolute changes in Ko produced by KCl infusion may cause 
relatively large changes in EK and transmembrane potential, without significantly 
altering intracellular or total body potassium levels.  Accordingly, the objectives 
of the studies here reported were: 
 
1) to investigate changes in the ventricular defibrillation threshold produced by 
changes in extracellular potassium ion concentration (Ko) in dogs; 
2) to hold total body potassium  content essentially constant during these studies; 
3) to measure the intracellular  potassium ion concentration (Ki) of the ventricular 
myocardium; and 
4) to plot defibrillation threshold as a function of EK = -61.5 log (Ki/Ko). 
 
If indeed defibrillation is analogous to cardiac pacing, the defibrillation threshold should 
be a decreasing function of EK that approaches zero as EK approaches the cellular firing 







Healthy mongrel dogs weighing 7-20 kilograms served as subjects. Anesthesia was 
induced with intravenous pentobarbital sodium (25-30 mg/kg) and maintained with 
additional 2 mg/kg boluses as necessary. This anesthetic alone does not alter the 
defibrillation threshold (10).  No other drug except potassium chloride was 
administered. Esophageal temperature, the ECG, aortic blood pressure, respiratory 
minute volume, and arterial blood pH, pCO2 , and pO2 were monitored as described 
previously (11).  One hour before the beginning of defibrillation threshold 
measurements, the right and left ureters were ligated through a midline laparotomy to 




Defibrillation threshold was determined three times during the 120 min period 
before potassium administration, and three times during the 120 min period after 
potassium administration. Details of the procedure for measuring defibrillation 
threshold have been reported previously (11, 12).  In brief, threshold was 
determined by repeated trials of fibrillation and transchest defibrillation, each with  
a damped sinusoidal defibrillator shock of peak current amplitude 10% less than the 
amplitude of the preceding shock.  (The defibrillator had a capacitance of 16 µF, an 
inductance of 44 mH and an internal-resistance of 7  (13).) A bipolar catheter 
electrode was placed in the right ventricle via a jugular venous cut-down to initiate 
ventricular fibrillation with 3 sec bursts of 60 Hz electrical stimuli.  The lowest 
shock intensity able to achieve defibrillation, and differing no more than 10% in 
amplitude from an intensity that did not defibrillate was defined as threshold.  
 
The hearts of the animals were never permitted to fibrillate more than 30 sec prior to 
defibrillation and never refibrillated until arterial blood pressure had returned to a 
stable level. The peak voltage and peak current for each shock were recorded on a 
storage oscilloscope. Only data from the first shocks applied after the onset of 
ventricular fibrillation were used in the calculation of threshold. Delivered energy 
was calculated as previously described (13). 
 
Plasma levels of sodium and potassium in arterial blood were monitored at 10-20 
min intervals using an Instrumentation Laboratories Model 443 flame photometer. 
After the first three pre-drug threshold determinations, intravenous potassium 
chloride in a dose of 1.0 mEq/kg was given slowly over a period of 5-10 min as the 
ECG was closely monitored for arrhythmias. Following this injection, a slow 
infusion of potassium chloride at 0.01 mEq/kg/min was begun using a motor 
driven syringe. After stable, elevated levels of plasma potassium were attained, 
three more measurements of the defibrillation threshold were made during the 
120 min following the onset of potassium administration. This dosage regimen was 
selected because it produced in preliminary experiments the greatest stable elevations of 
serum potassium that could be tolerated during repeated episodes of ventricular 
fibrillation and defibrillation. With higher levels of potassium intoxication, some 
animals did not recover from post defibrillation A-V block and hypotension. 
 
 
Measurement of intracellular potassium concentration by a double perfusion technique 
 
Because it is physically impossible to separate the intracellular and extracellular fluid 
compartments of solid tissues, intracellular potassium concentration must be calculated 
indirectly. The calculation can be made from measurements of total tissue and extracellular 




Kt = overall potassium concentration of myocardial tissue,  o = volume fraction of the 
 
extracellular space, and i = volume fraction of the intracellular space = (1-o) for heart 




provided o ,  the volume fraction of the extracellular space, is known. Classically, o  is 
measured as the volume of distribution of an indicator substance which is permeable to 
capillaries, but which is excluded from cells.  24Na, thiosulfate, and mannitol have been 
used as indicators for this purpose (14). The method developed for the present studies 
employs nonisotopic sodium as the indicator substance. This indicator is subtracted 
rather than added to the extracellular space as the myocardium is perfused with two 
different isotonic solutions, the first (lactated Ringer's solution) containing physiologic 
sodium concentration and the second (5% dextrose in water) containing zero sodium 
concentration. Samples of tissue and perfusate are analyzed for total sodium and 






After completion of the defibrillation threshold measurements, the potassium infusion 
was stopped and median sternotomy and pericardiotomy were performed. The heart was 
perfused first with lactated Ringer's solution and then with 5% dextrose in water via a 
cannula placed in the left brachiocephalic artery. All other branches of the aortic arch 
except the coronary arteries were ligated.  Before perfusion, the cavae and descending 
thoracic aorta were clamped; the atria were cut to promote drainage of blood and 
perfusate. After perfusion with 500 ml of lactated Ringer's solution, a 1 gram sample of 
right ventricular muscle nourished by the left anterior descending coronary artery was 
excised for assay of sodium and potassium content. Then perfusion with 500 ml of 
dextrose solution was carried out and a 1 gram sample of right ventricular muscle 
nourished by the right coronary artery was excised for assay of tissue sodium and 
potassium content. The assay procedure employed overnight digestion of the tissue 
sample in 10 volumes of 1 molar H2SO4 at 80°C.  Such digestion for one hour or longer 
produced maximal recovery of sodium and potassium from the pieces of myocardium. 
Assay of the supernatant solution for sodium and potassium concentration was 
accomplished using the flame photometer, calibrated with solutions of 1 molar H2SO4 
containing known concentrations of Na+ and K+ ions.  Samples of coronary sinus effluent 
taken after perfusion with 400 ml of each solution provided a measure of extracellular 










Total tissue sodium concentration, Nat, is given by the expression 
 
iioot NaNaNa  , 
 
where, as before, o = volume fraction of the extracellular space i  = 1- o  = 
volume fraction of the intracellular space, Nai = intracellular sodium concentration, 
and Nao = extracellular sodium concentration.  During the perfusion procedure, o, i, 


















assuming that sodium ions distributed only to the extracellular space and did not 
cross cell membranes significantly during the period of perfusion.  Intracellular 














Investigation of higher levels of Ko 
 
The potassium treatment schedule for the first ten animals just described was designed to 
produce stable elevations of  extracellular potassium concentration near the maximal levels 
tolerated by the animals, without profound hypotension, depression of the sinoatrial or 
atrioventricular nodes, or intractable tachyarrhythmias.  In preliminary experiments 
such complications did occur with more rapid rates of potassium infusion. Consequently, 
to elucidate the influence of high concentrations of extracellular potassium upon 
defibrillation threshold, a second experiment was designed to determine at what 
concentration of extracellular potassium the ventricles of dogs would spontaneously 
defibrillate, that is, at what level of Ko defibrillation threshold was zero. These studies 
were carried out in open-chest dogs in whom cardiac output was maintained by a left 
ventricular bypass pump. The problem of circulatory collapse produced by very high levels 
of plasma potassium was thus obviated. No defibrillator was needed for the study. Neither 
was it necessary to establish a control level of the defibrillation threshold, since zero 
threshold current is equivalent to zero percent of control in any case. 
 
Nine pentobarbital anesthetized dogs served as subjects in this second experiment. 
After median sternotomy and pericardiotomy had  been performed, surgical hemostasis 
secured, and heparin (2 mg/kg i.v.) administered, ventricular fibrillation was initiated by 
60 Hz stimulation of the right ventricular surface. Each animal was immediately placed on 
 
a La Farge-type left ventricular bypass system. Blood was withdrawn from the left 
ventricle through a large bore, multiple side-hole cannula inserted through a small stab 
wound in the cardiac apex. Blood withdrawn from the left ventricle was led through a 
Travenol roller pump and re-infused into the animal via a large bore, right-angle cannula 
previously placed in the abdominal aorta. Prior to institution of the bypass, the tubing was 
filled with warmed (30-40 °C) Ringer's solution. Care was taken to ensure that the left 
ventricular cannula was not pushed through the aortic valve from the left ventricle, since a 
short circuit would have been created.  To remove venous return, the animal's hindquarters 
were elevated 30 degrees and up to 1000 ml of additional Ringer's solution infused as 
necessary to maintain a stable artificial cardiac output. 
 
After the bypass system had been adjusted, potassium chloride was infused via the 
femoral vein at a rate of 0.2 mEq/kg/min, calculated to raise the extracellular potassium 
concentration by approximately 1 mEq/L/min.  Esophageal temperature, the ECG, arterial 
blood pressure, and arterial blood pH, pCO2, and pO2 were monitored.  Two arterial 
blood samples were taken at the time of spontaneous, chemical defibrillation for analysis 
of plasma potassium concentration. The first sample was taken at the moment fibrillation 
appeared to cease, as judged by the ECG and direct visual inspection of the heart. The 
second sample was taken when defibrillation was confirmed by electrical pacing of the 
ventricles by single 10 volt, 2 msec stimulus applied to the ventricular surface with hand-
held bipolar electrodes. Generation of ventricular ectopic beats in the ECG was taken as 
confirmation of ventricular defibrillation. The average plasma potassium concentration of 
the first and second samples was taken as the level required for defibrillation with zero 





The elevation of plasma potassium concentration produced by the "bolus plus infusion" 
technique in ten dogs is illustrated in Figure 1.  The technique described produced a 
stable plateau of extracellular potassium concentration for defibrillation studies. The 
overall mean control potassium level was 3.9 mEq/L and the overall potassium infusion 
level was 7.5 mEq/L. Calculated levels of intracellular potassium concentration in four 
of these animals and in four animals which did not receive prior potassium infusions 
are given in Table 1. The mean value for intracellular potassium was 91 mEq/L and the 
standard error of the mean was 3.6 mEq/L. Intracellular potassium concentrations of dogs 
that received potassium treatment were not significantly different from those of dogs that 







Figure 1.  Elevation  of  plasma  potassium in 10 dogs produced by a slow intravenous 
injection of potassium chloride, 1.0 mEq/kg, followed by a constant infusion of 




Table 1.  Ionic concentrations in canine ventricular muscle. o = volume fraction of 
extracellular space; Nat = tissue sodium concentration; Kt tissue potassium concentration; 
Nai, = intracellular sodium concentration; Ki intracellular potassium concentration. Prior 
KCl = KCl 1.0 mEq/kg i.v. slowly, followed by KCl 0.01 mEq/kg/min for 120 min. 
Student's t values (two-tailed) test the null hypothesis that tabulated values for dogs 1-4 
(no prior KCl) are equal to tabulated values for dogs 5-8 (prior KCl treatment). Prior KCl 






























2 no 0.26 45 82 15 109 
3 no 0.15 31 71 14 83 
4 no 0.20 36 69 11 85 
5 yes 0.26 40 75 7 99 
6 yes 0.18 29 73 6 88 
7 yes 0.17 34 76 17 90 













S.D.  0.047 5.2 8.1 4.3 10.2 
     t  0.66 0.38 -0.95 1.63 -0.66 




Figure 2 summarizes the effects of increased extracellular potassium concentration on 
ventricular defibrillation threshold. Defibrillation threshold as percent of control is 
plotted as a function of plasma potassium concentration and of calculated potassium 
equilibrium potential. The left-hand and middle data points represent mean control and 
mean post-potassium threshold values. The right-hand data point represents the mean 
plasma potassium concentration for spontaneous defibrillation with zero current or 
energy. The upper scale for potassium equilibrium potential was calculated from the 
Nernst equation using the mean value of intracellular potassium concentration reported 
in Table 1.  As extracellular potassium concentration is increased, ventricular 
defibrillation threshold dramatically decreased, reaching zero value when Ko was 






Figure 2.  Effect of elevated extracellular potassium concentration on ventricular 
defibrillation threshold in dogs.  Results from both experimental protocols are 
combined.  Error bars represent  1 standard deviations.  The abscissa is broken to 
delineate standard deviation of potassium concentrations for spontaneous 
defibrillation (horizontal error bars).  Results are similar whether threshold shock 






As the potassium equilibrium potential, EK, is made less negative by KCl infusion, the 
gap between the theoretical equilibria for resting membrane potential and cellular 
firing threshold narrows. It is predicted that this change, in turn, will decrease the 
defibrillation threshold. As indicated in Figure 2, the decrease in defibrillation 
threshold is in fact related to the increase in EK , and defibrillation threshold falls to 
zero not far from the expected value of cellular firing threshold. The fact that the 
observed value of EK at zero defibrillation threshold is somewhat less negative than 
the typically quoted value of -60 mV for cellular firing threshold of ventricular fibers 
may be related to the critical mass concept of Zipes (3, 4).  According to this concept, 
depolarization of a large critical mass of ventricular muscle is required for 
defibrillation, including cells with higher-than-average threshold.  Hence, if complete 
defibrillation is taken as the endpoint, the calculated value of EK would be associated 
with the cells in the critical mass with the highest thresholds. In addition, measured 
plasma levels of Ko in the second experiment were undoubtedly slightly greater than 
tissue levels, since plasma concentrations were increasing and complete 
equilibration of plasma and interstitial compartments could not have occurred.  With 
these reservations, the results obtained are very close to those predicted by the 
hypothesis that defibrillation is a large scale analog of cardiac pacing. 
 
Although potassium concentrations in circulating plasma comparable to those used in 
the present study are not routinely encountered in the clinic, local tissue elevations in 
extracellular potassium may be quite significant in certain pathophysiologic states 
related to defibrillation. For example, Tacker et al. (16) found a dose-related decrease in 
defibrillation threshold current and energy in dogs following toxic doses of the digitalis 
glycoside, ouabain.  A dose of 50 µg/kg produced a n  average maximum decrease in 
threshold energy of 20%, a finding virtually identical to that reported earlier by 
Lown et al. (17) 
 
These findings are consistent with the effects of potassium reported in this paper and 
may be explained as an indirect effect of the well-known inhibition of membrane-
bound sodium/potassium ATPase by digitalis glycosides. This cellular effect of 
digitalis preparations causes inhibition of active transport of sodium ions out of and 
potassium ions into myocardial cells. As a result, there is a net outward leakage of 
potassium ions (18) which could produce local elevations in extracellular potassium 
concentration with resultant enhanced excitability and depression of the defibrillation 
threshold. 
 
These indirect alterations in defibrillation threshold by induced changes in local 
extracellular potassium concentration may also explain the recent (unpublished) 
observation in our laboratories that defibrillation threshold decreases following 




In addition to depression of defibrillation threshold, we have found in preliminary 
experiments that the potassium concentration of blood recovered from the coronary 
vascular bed increases progressively as the duration of fibrillation and cardiac anoxia 
is lengthened. This shift of potassium from intracellular to extracellular fluid 
compartments during ischemia has been demonstrated in several animal models (19, 
20, 21). 
 
Hence, although elevations of extracellular potassium concentration as great as those 
reported in the present studies would never be produced for therapeutic reasons, the 
finding of threshold depression by potassium may be important in understanding both 
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